Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Insulin Resistance in Postmenopausal Women
NCT06806345Phase 2Recruiting
- Sponsor
- Cairo University
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Cairo University. Primary endpoints: Hemoglobin A1c at 2 months, Function at 2 months and 1 more. Started Jan 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06806345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06806345.